title: Chelation for diabetes complications: A neglected approach?
abstract: ,Zou1,,。,,,,,2-4。、、、56,。2(T2D),、、7。1,,8。,,(TETA),、D-9。 ,。,TETAT2D10;11,12。24,50T2D,EDTA,EDTA13。,1708EDTA,18%14,63341%, +15,16;17。 ?、、,,18。Zou1,。.
authors.affiliation: Icahn School of Medicine at Mount Sinai.
authors.forename: Zachary
authors.initials: Z
authors.lastname: Bloomgarden
mesh_terms: D000818:Animals; D002614:Chelating Agents / Q000627:therapeutic use*; D048909:Diabetes Complications / Q000188:drug therapy*; D004195:Disease Models, Animal; D006801:Humans; D018384:Oxidative Stress / Q000187:drug effects
chemical_list: D002614:Chelating Agents